Literature DB >> 22921244

Salvage endoscopic nasoseptal flap repair of persistent cerebrospinal fluid leak after open skull base surgery.

Jean Anderson Eloy1, Evelyne Kalyoussef, Osamah J Choudhry, Soly Baredes, Chirag D Gandhi, Satish Govindaraj, James K Liu.   

Abstract

PURPOSE: Persistent cerebrospinal fluid (CSF) rhinorrhea after open skull base surgery can be challenging to manage due to the risk of meningitis, brain abscess, surgical morbidity associated with revision craniotomy, and the lack of available healthy autologous tissue after failure of a pericranial flap. Given the recent success of the vascularized pedicled nasoseptal flap (PNSF) for reconstruction after endoscopic skull base surgery, we have adopted this technique as a salvage method to treat recalcitrant CSF rhinorrhea after previous open skull base surgery in order to avoid revision craniotomy. To our knowledge, use of the PNSF in this setting has not been previously described in the literature.
METHODS: A retrospective analysis was performed on 4 patients who underwent endoscopic endonasal PNSF repair of persistent CSF rhinorrhea after having undergone previous open transcranial skull base operation. Pathologies consisted of one sinonasal anterior skull base squamous cell carcinoma, one recurrent petrosal skull base meningioma, and 2 traumatic gunshot wounds to the head.
RESULTS: All 4 patients underwent successful repair of CSF rhinorrhea without complications using the salvage endoscopic endonasal PNSF technique after a mean follow-up of 21.5 months.
CONCLUSIONS: In patients who have undergone previous open skull base surgery as the primary approach, persistent CSF rhinorrhea can be safely repaired using the vascularized PNSF via an endoscopic endonasal approach. This minimally invasive strategy has the advantage of providing new healthy vascularized tissue for skull base reconstruction while avoiding revision craniotomy.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22921244     DOI: 10.1016/j.amjoto.2012.07.005

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  7 in total

Review 1.  Comprehensive review on rhino-neurosurgery.

Authors:  Werner Hosemann; Henry W S Schroeder
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2015-12-22

2.  Sandwich grafting technique for endoscopic endonasal repair of cerebrospinal fluid rhinorrhoea.

Authors:  Magdy Eisa Saafan; Osama A Albirmawy; Mohamed Osama Tomoum
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-08-28       Impact factor: 2.503

3.  Sphenoid Mucocele: A Complication of Skull Base Reconstruction with Nasoseptal Flap-A Critical Review and Our Experience.

Authors:  T N Janakiram; Abhilasha Karunasagar
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2019-07-26

4.  Primary Repair of Posteriorly Located Anterior Skull Base Dural Defects Using Nonpenetrating Titanium Clips in Cranial Trauma.

Authors:  Camille K Milton; Bethany J Andrews; Cordell M Baker; Kyle P O'Connor; Andrew K Conner; Michael E Sughrue; Kibwei A McKinney; Edward T El Rassi; Jose A Sanclement; Chad A Glenn
Journal:  J Neurol Surg B Skull Base       Date:  2020-11-26

5.  Utilization of the Nasoseptal Flap for Repair of Cerebrospinal Fluid Leak after Endoscopic Endonasal Approach for Resection of Pituitary Tumors.

Authors:  Murugappan Ramanathan; Michael Lim; Remi A Kessler; Tomas Garzon-Muvdi; Eileen Kim
Journal:  Brain Tumor Res Treat       Date:  2019-04

6.  Assessment of mucocele formation after endoscopic nasoseptal flap reconstruction of skull base defects.

Authors:  Qasim Husain; Saurin Sanghvi; Olga Kovalerchik; Pratik A Shukla; Osamah J Choudhry; James K Liu; Jean Anderson Eloy
Journal:  Allergy Rhinol (Providence)       Date:  2013

7.  Use of the Hadad-Bassagasteguy flap for repair of recurrent cerebrospinal fluid leak after prior transsphenoidal surgery.

Authors:  Joseph Brunworth; Tina Lin; David B Keschner; Rohit Garg; Jivianne T Lee
Journal:  Allergy Rhinol (Providence)       Date:  2013
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.